Over 134,000 cancer cases went undiagnosed in the U.S. during the first 10 months of the COVID-19 pandemic, according to a new University of Kentucky Markey Cancer Center study.
Tag: Cancer
Kidney cancer treatments and tumor biology can activate different immune-modifying processes in patients
The findings out of Dana-Farber Cancer Institute highlight that the mechanisms of immune modulation are different in patients treated with immunotherapy and anti-angiogenic combinations. The results also point to the role of tumor biology in the diversity and actions of tumor-infiltrating immune cells brought into action by these treatments. The findings might be important for predicting or understanding treatment outcomes in advanced kidney cancer.
A Mount Sinai-Led Study Shows Early Success of a Novel Drug in Treating a Rare and Chronic Blood Cancer
Results of 16-Center REVIVE trial published in The New England Journal of Medicine
Uniformed Services University to Represent DoD in New Cancer Screening Research Network
To identify cancers earlier and better understand when they may be easier to treat, the National Cancer Institute (NCI), part of the National Institutes of Health, has launched a new clinical trials network to evaluate emerging technologies for cancer screening.
UNC Lineberger named as a national research hub for NIH cancer screening study
UNC Lineberger Comprehensive Cancer Center has been selected as one of nine national research sites for the National Cancer Institute’s newly launched Cancer Screening Research Network, which will evaluate promising and emerging cancer screening technologies.
Stemming colorectal cancer in Latin America
Little is known about colorectal cancer screening strategies throughout the Western Hemisphere, with the exception of the U.S. and Canada.
U of T-led study finds positive support from parents and clinicians for pediatric cancer pain management app
A recent study led by Assistant Professor Lindsay Jibb of the Lawrence Bloomberg Faculty of Nursing and Scientist at The Hospital for Sick Children (SickKids) found that parents of young children with cancer, along with pediatric cancer clinicians are in favour of an app-based solution that Jibb and her team are creating, to help parents manage their child’s cancer pain at home.
Avanço no tratamento do câncer de pâncreas com cirurgia robótica total de Whipple
As novas tecnologias estão melhorando o tratamento do câncer de pâncreas, oferecendo esperança aos pacientes que enfrentam uma das formas de câncer mais letais. O procedimento de Whipple, uma cirurgia complexa para o câncer de pâncreas localizado, agora pode ser feito roboticamente.
New cell-based immunotherapy offered for melanoma
Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.
Avance en el tratamiento del cáncer de páncreas con cirugía robótica total de Whipple
Las nuevas tecnologías están mejorando el tratamiento del cáncer de páncreas, ofreciendo esperanza a los pacientes que enfrentan una de las formas de cáncer más letales. El procedimiento de Whipple, una cirugía compleja para el cáncer de páncreas localizado, ahora se puede hacer robóticamente.
National Breast Cancer Foundation Gives Grant to Help Breast Care Center Patients at Texas Tech Physicians of El Paso
In addition to assisting with access to care, such as transportation and general needs like groceries, the grant will allow the Breast Care Center to screen for mental and emotional distress using tablets. Currently, patients participate in an online distress screening survey that prompts questions about financial and psychosocial stressors in a patient’s life.
Giant step forward to help treat chronic wounds that affect millions
A team of international scientists has developed a more effective treatment for chronic wounds that does not involve antibiotics or silver-based dressings, but an ionized gas called plasma.
In Memoriam: Jonathan W. Uhr, M.D., renowned immunologist and longtime Chair of Microbiology
Jonathan W. Uhr, M.D., Professor Emeritus of Immunology at UT Southwestern Medical Center, who discovered how antibodies are made and developed a technique that led to the early detection of cancer cells, died Feb. 15. He was 96. Dr. Uhr was a member of the National Academy of Sciences and the American Academy of Arts and Sciences.
The Center to Eliminate Cancer Inequity to address unequal burden of cancer driven by health disparities
A new center at the University of Chicago Medicine will provide strategic leadership to bring together researchers, healthcare providers and community members to eliminate Chicago’s chronic cancer disparities.
New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial
An innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but rapidly fatal type of cancer with few effective treatment options, according to results from a clinical trial led by Queen Mary University of London.
Medical experts available for March: Colorectal Cancer Awareness, safe sleep & SIDS, returning to sports after injury, sleep aids, and habits to avoid for your brain health
As you plan healthcare coverage for March, Ochsner Health has experts on standby to cover several topics. Are younger people getting colorectal cancer?: Colorectal cancer has always been a cause for concern among middle-aged and older men and women. However,…
Pancreatic cancer hijacks a brain-building protein
Scientists at Cold Spring Harbor Laboratory (CSHL) and the University of California, Davis have reached a new breakthrough in pancreatic cancer research—eight years in the making.
NFL Veteran Chris Draft Joins ACSM’s Moving Through Cancer Task Force Board
The American College of Sports Medicine and its Exercise is Medicine Program (EIM) announced today that former NFL linebacker Chris Draft has joined the Moving Through Cancer Task Force Board.
Clues to early onset colorectal cancer found in microbiome of Hispanic patients
Nina Sanford, M.D., Chief of Gastrointestinal Radiation Oncology Service, UT Southwestern Medical Center Most people have a screening colonoscropy around age 50, however recent research has uncovered a rise in early onset colorectal cancer in patients younger than 50. What can…
Drug used for cocaine addiction may pave way for new treatment of advanced colon cancer
New research from the University of Ottawa proposes using vanoxerine as a safe method for potentially eliminating cancer stem cells in colorectal tumors.
New assay identifies clinically relevant gene fusions in pediatric tumors more accurately and efficiently
Researchers at Children’s Hospital Los Angeles report in The Journal of Molecular Diagnostics about a new tool that effectively integrates data from four fusion callers and identifies disease-related gene fusions.
New B.C. Self-Screening Program Will Improve Accessibility of Cervical Cancer Testing
The launch of British Columbia’s province-wide program offering the first-ever option to self-screen for HPV in Canada will enhance access to cervical cancer screening for women and individuals with a cervix. Offering a more convenient, accessible way to screen for…
Chula Researcher’s Innovative Wireless Hepatitis B Test Kit for Complete Screening and Data Collection in One Step
Chula researchers have developed a remarkable wireless hepatitis B virus test kit to screen for infection and collect data for an online database that’s fast and complete in one step.
Sandalwood Oil By-product Prevents Prostate Cancer Development in Mice
Sandalwood oil has been used worldwide for centuries. Now, a study is the first to demonstrate in vivo the chemo-preventive properties of a by-product of the oil in a mouse model. Results show administering alpha-santalol reduced visible prostate tumors, protected the normal tissue, and delayed progression from a precancerous condition to a high-grade form of cancer. These findings are significant because mortality in prostate cancer patients is mainly attributable to advanced stages of the disease.
Sister cells uncover pre-existing resistant states in cancer
Labeling cancer cells with genetic barcodes
“In ReSisTrace, we label cancer cells uniquely with genetic barcodes and allow them to divide once, so that we get two identical sister cells that share the same barcode.
New tumor spatial mapping tool will help clinicians assess aggressiveness of cancer and personalize treatment
Scientists have developed a new AI tool that maps the function of proteins in a cancerous tumour, enabling clinicians to decide how to target treatment in a more precise way.
Clues to cancer drug’s deadly side effects could make it safer
For some leukemia patients, their only treatment option carries a risk of heart failure
New Research Shows Patients with Cancer who Suffered a Major Adverse Financial Event More Likely to be Diagnosed With Advanced Stage Disease
New findings led by researchers at the American Cancer Society and the National Cancer Institute show more than one-third of cancer patients had a major adverse financial event – bankruptcy, lien, or eviction – before their cancer diagnosis.
$1.1M Grant Supports Research in Breast Cancer Survivorship among Black Women
Bo (Bonnie) Qin, PhD, researcher and cancer epidemiologist in the Section of Cancer Epidemiology and Health Outcomes at Rutgers Cancer Institute of New Jersey, has received $1.1M from the American Cancer Society to support her research on the impact of lifestyle patterns, social determinants of health, and inflammatory mechanisms on breast cancer survivorship among Black women.
Artificially intelligent software provides a detailed look at jets of plasma used to treat cancer
Artificially intelligent software has been developed to enhance medical treatments that use jets of electrified gas known as plasma. Developed by researchers at Princeton Plasma Physics Laboratory and the George Washington University, the computer code predicts the chemicals emitted by cold atmospheric plasma devices, which can be used to treat cancer and sterilize surfaces.
Director of Oncology Services Northern Region Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
George Raptis, MD, MBA, begins role at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health as director of Oncology Services for the Northern Region of New Jersey.
UChicago Medicine among the first to offer histotripsy for liver tumors
UChicago Medicine was the first hospital in Illinois to treat patients using histotripsy, a new noninvasive technology that uses ultrasound energy to precisely destroy liver tumors.
Memorial Sloan Kettering Cancer Center Launches Bilingual Campaign Promoting Screenings in the Hispanic Community
Today, Memorial Sloan Kettering Cancer Center (MSK), in collaboration with Miami-based creative agency Alma, launched a bilingual public service campaign to promote the importance of routine cancer screenings.
New Prostate Cancer Report Card keeps treatment options simple to understand
A new prostate cancer resource – the Prostate Cancer Outcomes Report Card – hopes to make it easier for men and their families to better understand the treatment options and outcomes.
New Potential Immunotherapies for Pancreatic Cancer
Pancreatic cancer can be a devastating diagnosis due to its extremely aggressive nature and low survival rate.
New Cancer Research Plan Aims to Improve Quality of Life for Cancer Survivors
CIHR’s Institute of Cancer Research (ICR) is launching a new five-year plan with cancer survivorship as a priority research topic. With the rate of cancer survivorship predicted to increase steadily over the next decades, survivor research will promote the Canadian…
La salud de las mamas durante la menopausia
Su riesgo de tener cáncer de mama aumenta con la edad, especialmente después de la menopausia. Alrededor de 8 de cada 10 casos de cáncer de mama ocurren en mujeres de más de 50 años.
Expert Analysis: Black Americans Have Highest Cancer Mortality Rates In The United States
For Black History Month, Hackensack Meridian Health offers experts on some of the reasons behind higher cancer rates in the Black community and how to reverse the trends.
Mapeamento dos comportamentos celulares em glioma de alto grau para a melhora do tratamento
Gliomas de alto grau são tumores cancerígenos que se espalham rapidamente no cérebro ou na medula espinhal.
Mapeo de los comportamientos celulares en glioma de alto grado para la mejora del tratamiento
Los gliomas de alto grado son tumores cancerígenos que se propagan rápidamente en el cerebro o en la médula espinal.
Brain Protein’s Virus-Like Structure May Help Explain Cancer-Induced Memory Loss
In a rare but serious complication of cancer, the immune system can start attacking the brain, causing rapid memory loss. What triggers this was largely unknown. Now, researchers at University of Utah Health have found that some tumors can release a virus-like protein, kickstarting an out-of-control autoimmune reaction.
Show Your Heart Love for American Heart Month — Johns Hopkins Medicine Adult and Pediatric Experts Available to Discuss Heart Health
February is American Heart Month, a time for awareness of heart-related conditions that affect adults and children. Johns Hopkins Medicine experts are available all month to discuss various aspects of heart health.
Weight loss intervention in people with type 2 diabetes influences cancer-associated proteins
A weight loss intervention in people with type 2 diabetes was found to alter levels of cancer-related proteins, according to the findings of a new University of Bristol-led study.
New technology makes cancer easier for immune system to find and destroy
A new technology to increase visibility of cancer cells to the immune system using CRISPR has been developed, and could lead to a new way to treat cancer.
Fighting Viruses that Cause Cancer
In research labs and clinical settings, faculty across Tufts School of Medicine and Graduate School of Biomedical Sciences are investigating cancer caused by herpes, HIV, HPV, and other viruses
Researchers Discover Why One Type of Chemotherapy Works Best in Bladder Cancer
Tisch Cancer Institute researchers discovered that a certain type of chemotherapy improves the immune system’s ability to fight off bladder cancer, particularly when combined with immunotherapy, according to a study published in Cell Reports Medicine in January.
Hackensack Meridian Health Selected as Inaugural Member of ARPA-H Investor Catalyst Hub Spoke Network
HMH joins nationwide network working to accelerate transformative health solutions
Computer Models Fill Critical Knowledge Gaps to Help Reduce Cancer Disparities
Reducing health disparities in incidence and mortality for major types of cancers can be aided by sophisticated computer modeling efforts, according to new, wide-ranging perspectives from researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues around the country.
AACI Congratulates Dr. Monica Bertagnolli on Confirmation as NIH Director
The Association of American Cancer Institutes (AACI) congratulates Monica Bertagnolli, MD, on her U.S. Senate confirmation today as the next director of the National Institutes of Health (NIH).
Improving the efficacy of cancer immunotherapy with modified CAR-T cells
CAR-T cell therapy is a last hope for many patients with blood, bone marrow or lymph gland cancer when other treatments such as chemotherapy are unsuccessful. A limiting factor of this otherwise very effective and safe therapy is that the cells used in the process quickly reach a state of exhaustion.